Business Context and Reporting Period
This Form 8-K was filed by MTBC, Inc. (d/b/a Carecloud, Inc.) on April 3, 2019. The registrant is an emerging growth company incorporated in Delaware. The report details the closing of an acquisition by the company's wholly-owned subsidiary, MTBC-Med, Inc.
Key Financial Metrics
The filing discloses a specific transaction value but does not provide consolidated revenue, profit, cash flow, margin, debt, or liquidity metrics for the reporting period.
- Acquisition Purchase Price: $1.6 million (increased from an initial $1.5 million).
- Target Company: Etransmedia Technology, Inc. ("ETI") and its subsidiaries.
- Closing Date: April 3, 2019 (with a retroactive closing date of April 1, 2019).
Material Changes
The primary material change is the expansion of the company's service portfolio through the acquisition of ETI. The purchase price was amended upward by $100,000 from the previously disclosed agreement dated March 27, 2019. ETI provides medical billing, practice management, credentialing, transcription, record retention, and request for information services to hospitals and physician practices.
Outlook, Risks, and Unusual Items
Management Commentary and Agreements:
- Non-Compete: Sellers and Formativ Health Management, Inc. are prohibited from competing with the company or soliciting acquired clients for three years post-closing.
- Transition Services: Sellers will provide certain employees for a transitional period at the company's expense.
- Indemnification: Provisions are capped at the purchase price, except for pre-closing liabilities which are uncapped.
Risks and Contingencies: The filing does not explicitly list new risks beyond standard acquisition contingencies (e.g., uncapped pre-closing liabilities). No forward-looking financial guidance is provided in this specific report.
Investor Verification Checklist
- Verify the final purchase price of $1.6 million and the retroactive closing date of April 1, 2019.
- Review the attached Amended and Restated Asset Purchase Agreement (Exhibit 10.1) for specific indemnification exclusions.
- Confirm the scope of the three-year non-compete and non-solicitation clauses.
- Assess the impact of the acquisition on future revenue streams given ETI's focus on Part B Healthcare Providers.